We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

64 hedge funds and large institutions have $25.9M invested in CTI BioPharma Corp. (DE) Common Stock in 2013 Q2 according to their latest regulatory filings, with 64 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $185K

Holders
64
Holders Change
+64
Holders Change %
–
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
64
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$185K
Net Calls
-$185K
Net Calls Change
-$185K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
51
Creative Planning
Kansas
$15K +$16.9K +1,442 New
Group One Trading
52
Group One Trading
Illinois
$14K +$16.1K +1,374 New
JG
53
Jefferies Group
New York
$12K +$13.4K +1,147 New
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$9K +$9.61K +820 New
Ameriprise
55
Ameriprise
Minnesota
$7K +$8.23K +702 New
Barclays
56
Barclays
United Kingdom
$6K +$6.95K +593 New
DADC
57
D.A. Davidson & Co
Montana
$2K +$2.34K +200 New
RFC
58
Russell Frank Company
Washington
$2K +$2.77K +236 New
Fifth Third Bancorp
59
Fifth Third Bancorp
Ohio
$1K +$1.02K +87 New
MFS
60
MSI Financial Services
Massachusetts
– +$23 +2 New
U
61
UBS
Switzerland
– +$94 +8 New
LTFS
62
Ladenburg Thalmann Financial Services
Florida
– +$410 +35 New
First Manhattan
63
First Manhattan
New York
– +$434 +37 New
TRCT
64
Tower Research Capital (TRC)
New York
– +$481 +41 New
1 2
3

CTIC Hedge Fund Activity: Q2 2013 in Review

64 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q2 2013, worth a combined $25.9M.

Buyers outnumbered sellers: 64 funds opened new CTIC positions and 0 closed out — a net gain of 64 holders — while 0 added to existing stakes and 0 trimmed.

  • 64 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $25.9M of CTI BioPharma Corp. (DE) Common Stock stock for Q2 2013.
  • 64 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q2 2013 and 0 closed out, a net change of +64 holders.

Based on aggregated 13F filings for Q2 2013.